Contemporary management of chronic pain disorders

Journal of Family Practice

Volumn 53, Issue SUPPL. 6, 2004, Pages

  McCarberg, Bill ^a,b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; BACLOFEN; BUPRENORPHINE; CAPSAICIN; CARBAMAZEPINE; CHOLINE MAGNESIUM TRISALICYLATE; CLONIDINE; CODEINE; DICLOFENAC; DIFLUNISAL; FENTANYL; GABAPENTIN; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; INDOMETACIN; LAMOTRIGINE; LEVORPHANOL; LIDOCAINE; METHADONE; MORPHINE; NAPROXEN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGITATION; ANALGESIA; ANXIETY DISORDER; ATAXIA; BLOOD DYSCRASIA; BURNING SENSATION; CARDIOVASCULAR DISEASE; CHRONIC PAIN; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; COMPLEX REGIONAL PAIN SYNDROME; CONFUSION; CONSTIPATION; DELIRIUM; DEPRESSION; DIPLOPIA; DIZZINESS; DROWSINESS; EXERCISE; FEEDBACK SYSTEM; GINGIVA HYPERPLASIA; HUMAN; HYPERALGESIA; HYPNOSIS; HYPOTENSION; LIVER DYSFUNCTION; LIVER TOXICITY; LONG TERM CARE; LOW BACK PAIN; MOOD; MYOCLONUS; NAUSEA; NEUROPATHIC PAIN; NEUROTOXICITY; NOCICEPTION; NUTRITION; ORTHOSTATIC HYPOTENSION; OSTEOARTHRITIS; PALLIATIVE THERAPY; PATIENT REFERRAL; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PHANTOM PAIN; PHYSICAL DISABILITY; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PRURITUS; RESPIRATION DEPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SEDATION; SKIN IRRITATION; SOCIAL SUPPORT; STEVENS JOHNSON SYNDROME; SWEATING; URINARY HESITANCY; VISUAL IMPAIRMENT; VOMITING; WEIGHT GAIN; WORLD HEALTH ORGANIZATION; XEROSTOMIA;

ARTHRITIS; CHRONIC DISEASE; DIET; DRUG THERAPY, COMBINATION; EXERCISE; HUMANS; LOW BACK PAIN; NOCICEPTORS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; PSYCHOTHERAPY; REFERRAL AND CONSULTATION;

EID: 5144223985     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Wootton RJ. Psychosocial assessment of chronic pain. In: Warfield CA, Bajwa ZH, eds. Principles and Practice of Pain Medicine. 2nd ed. New York, NY: McGraw-Hill; 2004:148-156.
2. Marcus DA. Tips for managing chronic pain. Implementing the latest guidelines. Postgrad Med. 2003;113:49-56, 59.
3. Anon. Cancer pain relief. 2nd ed. Geneva, Switzerland: World Health Organization: 1996.
4. Garcia Rodriguez LA, Hernandez-Diaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res. 2001;3:98-101.
5. Anon. Acetaminophen. In: McEvoy GK, ed. AHFS Drug Information. 2000 ed. Bethesda, Md: American Society of Health-System Pharmacists; 2000:1937-1945.
6. Grainger R, Cicuttini FM. Medical management of osteoarthritis of the knee and hip joints. Med J Aust. 2004;180:232-236.
7. Day R, Morrison B, Luza A, et al. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group. Arch Intern Med. 2000;160:1781-1787.
8. Bensen WG, Fiechtner JJ, McMillen JI, et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial Mayo Clin Proc. 1999;74:1095-1105.
9. Makarowski W, Zhao WW, Bevirt T, Recker DP. Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen. Osteoarthritis Cartilage. 2002;10:290-296.
10. Emery P, Zeidler H, Kvien TK, et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet. 1999;354:2106-2111.
11. Simon LS, Weaver AL, Graham DY, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. 1999;282:1921-1928.
12. Laine L, Harper S, Simon T, et al. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group. Gastroenterology. 1999;117:776-783.
13. Goldstein O, Eisen G, Bensen W, et al. SUCCESS in Osteoarthritis (OA) Trial: Celecoxib significantly reduces the risk of upper gastrointestinal (UGI) hospitalizations compared to diclofenac and narpoxen in 13,274 randomized patients with OA. Presented at: European League Against Rheumatism 2001 Annual Meeting, June 13-16, 2001, Prague, Czech Republic.
14. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000;284:1247-1255.
15. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000;343:1520-8, 2.
16. Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet, 2002;360:1071-1073.
17. Mamdani M, Rochon PA, Juurlink DN, et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclooxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ. 2002;325:624.
18. Ballantyne OC, Mao J. Opioid therapy fot chronic pain. N Engl Med. 2003;349:1943-1953.
19. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine. 1998;23:2591-2600.
20. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am. 1999;83:761-786.
21. Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage. 2003;26:1026-1048.
22. Bruera E, Kim HN. Cancer pain. JAMA. 2003;290:2476-2479.
23. Vielhaber A, Portenoy RK. Advances in cancer pain management Hematol Oncol Clin North Am. 2002;16:527-541.
24. Bruera E, Pereira J, Watanabe S, Belzile M, Kuehn N, Hanson J. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer. 1996;78:852-857.
25. Anon. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43:1905-1915.
26. Anon. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis. Glenview, Ill: American Pain Society; 2002.
27. Anon. The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50(suppl 6):S205-S224.
28. Caldwell JR, Rapoport RJ, Davis JC, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage. 2002;23:278-291.
29. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to non-steroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol. 1999;26:862-869.
30. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:853-860.
31. Goorman SD, Watanabe TK, Miller EH, Perry C. Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study. Arch Phys Med Rehabit. 2000;81:479-483.
32. Adams ME, Atkinson MH, Lussier AJ, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage. 1995;3:213-225.
33. Anon. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002;46:328-346.
34. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis. 2002;61:290-297.
35. Bogduk N. Management of chronic low back pain. Med J Aust. 2004;180:79-83.
36. van Tulder MW, Scholten RJ, Koes BW, Deyo RA. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2000;2:CD000396.
37. van Tulder MW, Touray T, Furtan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev. 2003;2:CD004252.
38. Institute for Clinical Systems Improvement. National Guideline Clearinghouse web site. Adult low back pain. Available at: http://www.guideline. gov/summary/ summary.aspx?ss=15&doc_id=4165&nbr-3190&string= chronic%20AND%20low%20AND %20back%20AND%20pain. Accessed August 7, 2004.
39. van Tulder MW, Malmivaara A, Esmail R, Koes BW. Exercise therapy for low back pain. Cochrane Database Syst Rev. 2000;2:CD000335.
40. Furlan AD, Brosseau L, Imamura M, Irvin E. Massage for low back pain. Cochrane Database Syst Rev. 2002;2:CD001929.
41. Cochrane Database of Systematic Reviews. Cochrane Database web site. Acupuncture for low-back pain. Available at: http://gateway2.ovid.com/ovidweb. cgi. Accessed August 7, 2004.
42. van Tulder MW, Ostelo RW, Vlaeyen JW, Linton SJ, Morley SJ, Assendelft WJ. Behavioural treatment for chronic low back pain. Cochrane Database Syst Rev. 2000;2:CD002014.
43. Milne S, Welch V, Brosseau L, et al. Transcutaneous electrical nerve stimulation (TENS) for chronic low back pain. Cochrane Database Syst Rev. 2001;2:CD003008.
44. Nelemans PJ, de Bie RA, de Vet HC, Sturmans F. Injection therapy for subacute and chronic benign low back pain. Cochrane Database Syst-Rev. 2000;2:CD001824.
45. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurot. 2003;60:1524-1534.
46. Bennett GJ. Neuropathic pain: new insights, new interventions. Hosp Pract (Off Ed). 1998;33:95-104, 107.
47. Schifitto G, McDermott MP, McArthur JC, et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology. 2002;58:1764-1768.
48. Galer BS, Dworkin RH. A Clinical Guide to Neuropathic Pain. Minneapolis, Minn: McGraw-Hill; 2000.
49. Guay DR. Adjunctive agents in the management of chronic pain. Pharmacotherapy. 2001;21:1070-1081.
50. Backonja M. Anticonvulsants for the treatment of neuropathic pain syndromes. Curr Pain Headache Rep. 2003;7:39-42.
51. Macres S, Richeimer S, Duran P. Adjuvant analgesics. In: Warfield CA, Bajwa ZH, eds. Principles and Practice of Pain Medicine. 2nd ed. New York, NY: McGraw-Hill; 2004:627-638.
52. Reisner L. Antidepressants for chronic neuropathic pain. Curr Pain Headache Rep. 2003;7:24-33.
53. Argoff CE: Targeted topical peripheral analgesics in the management of pain. Curr Pain Headache Rep. 2003;7:34-38.
54. Mason L, Moore RA, Edwards JE, McQuay HJ, Derry S, Wiffen PJ. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ. 2004;328:995.
55. Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004;328:991.
56. Beydoun A, Backonja MM. Mechanistic stratification of antineuralgic agents. J Pain Symptom Manage. 2003;25(suppl 5):S18-S30.
57. Harden N, Cohen M. Unmet needs in the management of neuropathic pain. J Pain Symptom Manage. 2003;25(suppl 5):S12-S17.
58. Haythornthwaite JA, Benrud-Larson LM. Psychological assessment and treatment of patients with neuropathic pain. Curr Pain Headache Rep. 2001;5:124-129.
59. Morley S, Ecceston C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain. 1999;80:1-13.
60. McCracken LM, Turk DC. Behavioral and cognitive-behavioral treatment for chronic pain: outcome, predictors of outcome, and treatment process. Spine. 2002;27:2564-2573.